Despite claims by the Obama administration that the Affordable Care Act will reduce health insurance companies' spending on overhead, insurers' financial filings show the law had no impact.
Despite claims by the Obama administration that the Affordable Care Act will reduce health insurance companies’ spending on overhead, thereby channeling a greater share of consumers’ premium dollars into actual patient care, insurers’ financial filings show the law had no impact on the percentage of insurer expenditures on such things as administration, marketing and profits.
Wednesday
That’s the chief finding of a team of researchers, including 2 prominent physicians on the faculties of the City University of New York’s School of Public Health and Harvard Medical School, in an article published in the peer-reviewed International Journal of Health Services.
Read the press release: http://bit.ly/1HN0oGL
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Bustling Gene Therapy Pipeline for Neuromuscular Diseases Brings Thorny Questions to the Clinic
March 18th 2025The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but also logistical hurdles and a need for complex discussions between clinicians and families.
Read More